Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis
Condition(s):Non-alcoholic Steatohepatitis (NASH)Last Updated:April 29, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Non-alcoholic Steatohepatitis (NASH)Last Updated:April 29, 2022Completed
Condition(s):Chronic Liver DiseaseLast Updated:June 29, 2021Recruiting
Condition(s):NASHLast Updated:March 1, 2024Recruiting
Condition(s):Liver Fibrosis; NASH; Liver DiseasesLast Updated:October 5, 2023Not yet recruiting
Condition(s):Liver CirrhosesLast Updated:October 5, 2023Recruiting
Condition(s):NAFLD; Liver Fibroses; Cardiovascular Diseases; Cardiovascular Risk FactorLast Updated:August 16, 2019Recruiting
Condition(s):DiabetesLast Updated:January 8, 2016Completed
Condition(s):Liver FibrosisLast Updated:February 24, 2014Completed
Condition(s):Liver FibrosesLast Updated:April 18, 2023Recruiting
Condition(s):Non-alcoholic SteatohepatitisLast Updated:February 9, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.